• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login

    Investing News NetworkYour trusted source for investing success

    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Company Market
    Company News
    Company Stocks
    • Company Market
    • Company News
    • Company Stocks

    Pomerantz Files Class action Lawsuit Against Uranium Energy

    Kristen Moran
    Jun. 30, 2015 11:11AM PST
    Company News

    Pomerantz LLP announced that it has filed a class action lawsuit against Uranium Energy Corp. (NYSE:UEC) and certain officers of the company. This follows an announcement on June 19 that the law firm was investigating claims on behalf of UEC investors.

    Pomerantz LLP announced that it has filed a class action lawsuit against Uranium Energy Corp. (NYSE:UEC) and certain officers of the company. This follows an announcement on June 19 that the law firm was investigating claims on behalf of UEC investors.

    As quoted in the press release:

    The class action, filed in United States District Court, Southern District of Texas, and docketed under 15-cv-01862, is on behalf of a class consisting of all persons or entities who purchased Uranium Energy securities between October 14, 2014 and June 17, 2015 inclusive (the “Class Period”).  This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

    If you are a shareholder who purchased Uranium Energy securities during the Class Period, you have until August 28, 2015 to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

    The Complaint alleges throughout the Class Period, defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (1) Uranium Energy stock achieved an unsustainable valuation by using paid stock promoters, yet failed to disclose the use of such promoters in its regulatory filings pursuant to Section 17(b) of the Securities Act of 1933; and (2) as a result of the foregoing, Uranium Energy’s public statements were materially false and misleading at all relevant times.

    Click here to read the full Pomerantz LLP press release.

    nyse:uecuranium energyunited states
    The Conversation (0)
    Go Deeper
    AI Powered
    Uranium Energy

    Uranium Energy

    American flag overlays a glowing nuclear power plant with cooling towers at sunset.

    Trump’s Nuclear Revival Plan Boosts Uranium Prices, Sends US Miners Soaring

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×